Pamela Clark
Campus: UMD | Building: SPH | Room: 1242D
Phone: (301) 405-8624 |

Research Focus

  • Characterization of manipulated tobacco products, such as menthol cigarettes and cigarettes with variation in smoke pH
  • Characterization and abuse liability assessment of alternative nicotine/tobacco products, such as hookah (water pipe), electronic nicotine delivery devices (e-cigarettes) and smokeless tobacco (snus)
Education and Training

Ph.D., Epidemiology, University of South Florida, Tampa, Florida, December 1993 
M.S.P.H., Biostatistics and Epidemiology, University of South Florida, December 1990
B.S.N., Nursing, University of South Florida, December 1988

Career Highlights

Research Professor, Department of Behavioral and Community Health 2008-present
Health Research Leader, Battelle Centers for Public Health Research and Evaluation 1998 - 2007
Associate Professor of Epidemiology, Northeastern Ohio Universities College of Medicine 1994 - 1998
Associate Professor of Medicine (Cardiology), University of South Florida College of Medicine 1993 - 1994


HLTH 301: Epidemiology for Public Health Practice

Honors and Awards

Recent Grants (within last 7 years)

National Institute on Drug Abuse, Abuse liability assessment and characterization of an electronic nicotine delivery system (e-cigarette), Principal Investigator

National Cancer Institute, Standardization of methods to measure waterpipe smoke emissions and exposures, Principal Investigator

National Institute on Drug Abuse, Physiologic impact of variation in smoke pH, Principal Investigator

National Cancer Institute, Smokers and PREPs: Measurement of inhaled and exhaled tobacco smoke particulate, Investigator

National Cancer Institute, Effect of true puff profile replication on machine-generated smoke constituents, Investigator

Centers for Disease Control and Prevention, Human smoking behavior study, Investigator

Centers for Disease Control and Prevention, Menthol cross-over study, Task Leader (Principal Investigator)

National Cancer Institute, Initiative on the study and implementation of systems (ISIS), Task Leader (Principal Investigator)

National Cancer Institute, Business practices and minors' access to tobacco, Principal Investigator

National Cancer Institute, Community surveillance of novel tobacco products, Principal Investigator


Clark PI, Babu S, Sharma E. Menthol Cigarettes. What do we know? Report to the World Health Organization, Study Group on Tobacco Product Regulation (TobReg), November 2008. 

Clark PI and Djordjevic MJ. The Role of Smoking Topography in Assessing Human Smoking and its Utility for Informing Machine-Smoking Protocols. Report to the World Health Organization, Scientific Advisory Committee on Tobacco Regulation (WHO SACTob), September 2003.

Gardiner P & Clark PI. Menthol cigarettes: Moving toward a broader definition of harm. Nicotine and Tobacco Research 12:S85-93 (2010). 

Leischow SJ, Luke DA, Mueller N, Harris JK, Ponder P, Marcus S, Clark PI. Mapping U.S. government tobacco control leadership: networked for success? Nicotine & Tobacco Research 12:888-94 (2010). 

Rogers JD, Biener L, Clark PI. Test marketing of new smokeless tobacco products in four US cities. Nicotine & Tobacco Research 12:69-72 (2010). 

Kim H, Clark PI. Cigarette smoking transition in females of low socioeconomic status: Impact of state, school and individual factors. Journal of Epidemiology and Community Health 2006;60(suppl_2):ii13-ii19. 

Clark PI, Schooley MW, Pierce B, Schulman J, Hartman AM, Schmitt CL. Impact of home smoking rules on smoking patterns among adolescents and young adults. Prev Chronic Dis [serial online] 2006 Available from: URL:

Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, Leischow S. Methods to assess potential reduced exposure products. Nicotine & Tobacco Research 2005;7:827-844.

Clark PI, Gardiner PS, Djordjevic MV, Leischow SJ, and Robinson RG. Menthol cigarettes: Setting the research agenda. Nicotine & Tobacco Research 2004;6:S5-S9.

Feighery EC, Ribisl KM, Schleicher N, and Clark PI. Retailer participation in cigarette company incentive programs is related to increased levels of cigarette advertising and cheaper cigarette prices in stores. Prev Medicine 2004;38:876-884. 

Feighery EC, Ribisl KM, Clark PI, and Haladjian HH. How the tobacco companies ensure prime placement of their advertising and products in stores: Interviews with retailers about tobacco company incentive programs. Tobacco Control 2003;12:184-188.

Trochim WMK, Stillman FA, Clark PI, and Schmitt CL. Development of a model of the tobacco industry's interference with tobacco control programs. Tobacco Control 2003;12:140-147.